Rehber bağlantılı sınav · Orta Seviye

AI in Liver Disease and Hepatology Quiz

Tests liver pathology scoring, ultrasound research, transplant-risk models, FDA qualification scope, and professional review.

Soru 1 arasında 8

For what setting did FDA qualify AIM-NASH as a drug-development tool?